Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 84 Neoplasm Metastasis 8 Neoplasms 6 Sarcoma 4 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Untreated Operable Early Breast Cancer 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Somatostatinoma 1 Solid Tumors 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1

Interventions

Cyclophosphamide 7 blinatumomab 6 Cytarabine 6 fludarabine 5 Mercaptopurine 5 Methotrexate 4 fludarabine phosphate 3 Vincristine 3 Rituximab 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Drug Therapy 3 Dexamethasone 3 Daunorubicin 3 Asparaginase 3 Whole-Body Irradiation 2 Vindesine 2 Thioguanine 2 Teniposide 2 Stem Cell Transplantation 2 Prednisolone 2 N,N-dicyclohexyl-isoborneol-10-sulfonamide 2 Interleukin-2 2 Doxorubicin 2 Cladribine 2 Blood Specimen Collection 2 Azacitidine 2 tisagenlecleucel 1 thymoglobulin 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasm, Residual × palbociclib × Clear all

NCT04130152 2022-10-25

PROMETEO II

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡